These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32173213)

  • 1. Risk awareness, medication adherence, and driving behavior as determined by the provision of drug information to patients.
    Fukuda Y; Ando S; Saito M
    Patient Educ Couns; 2020 Aug; 103(8):1574-1580. PubMed ID: 32173213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a Japanese drug alert pictogram on medication-taking/driving behavior.
    Fukuda Y; Ando S; Saito M
    Traffic Inj Prev; 2020; 21(1):18-23. PubMed ID: 31770002
    [No Abstract]   [Full Text] [Related]  

  • 3. Hospital outpatients' responses to taking medications with driving warnings.
    Smyth T; Sheehan M; Siskind V
    Traffic Inj Prev; 2013; 14(1):18-25. PubMed ID: 23259515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing changes in medication-taking and driving behavior after warnings about prescription medications that prohibit driving: an online survey.
    Fukuda Y; Saito M
    BMC Public Health; 2022 May; 22(1):1020. PubMed ID: 35596168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicines and driving: evaluation of training and software support for patient counselling by pharmacists.
    Legrand SA; Boets S; Meesmann U; Verstraete AG
    Int J Clin Pharm; 2012 Aug; 34(4):633-43. PubMed ID: 22678812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study comparing the effectiveness of three warning labels on the package of driving-impairing medicines.
    Emich B; van Dijk L; Monteiro SP; de Gier JJ
    Int J Clin Pharm; 2014 Dec; 36(6):1152-9. PubMed ID: 25204257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paediatrician knowledge, attitudes, and counselling patterns on teen driving.
    Weiss JC; O'Neil J; Shope JT; O'Connor KG; Levin RA
    Inj Prev; 2012 Feb; 18(1):10-5. PubMed ID: 21606471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Local Pharmacy Pharmacists' Responses to the Prescription of Drugs That Influence Driving].
    Nagata T; Yamada J; Oohara H; Kizu J
    Yakugaku Zasshi; 2017; 137(3):323-328. PubMed ID: 28250328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehension and acceptability of on-board traffic information: Beliefs and driving behaviour.
    Cristea M; Delhomme P
    Accid Anal Prev; 2014 Apr; 65():123-30. PubMed ID: 24456847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of chronic pain patients' psychotropic drug knowledge and warning labels on the decision whether to drive a car or not.
    Veldhuijzen DS; van Wijck AJ; Verster JC; Kalkman CJ; Kenemans JL; Olivier B; Volkerts ER
    Traffic Inj Prev; 2006 Dec; 7(4):360-4. PubMed ID: 17114093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors for patient knowledge and reported behaviour regarding driving under the influence of medicines: a multi-country survey.
    Monteiro SP; van Dijk L; Verstraete AG; Alvarez FJ; Heissing M; de Gier JJ
    BMC Public Health; 2012 Jan; 12():59. PubMed ID: 22264358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of driving-impairing medicines by a Spanish population: a population-based registry study.
    Gutierrez-Abejón E; Herrera-Gómez F; Criado-Espegel P; Alvarez FJ
    BMJ Open; 2017 Nov; 7(11):e017618. PubMed ID: 29170289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. I'm taking six different medications to manage my blood pressure, cholesterol, and diabetes. Should I be concerned about driving?
    Johns Hopkins Med Lett Health After 50; 2010 Jan; 21(11):8. PubMed ID: 20344818
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of lead time of verbal collision warning messages on driving behavior in connected vehicle settings.
    Wan J; Wu C; Zhang Y
    J Safety Res; 2016 Sep; 58():89-98. PubMed ID: 27620938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of curriculum to improve health professionals' ability to manage age-related driving impairments.
    Hill LL; Rybar J; Styer T
    Accid Anal Prev; 2013 Dec; 61():222-32. PubMed ID: 23127605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk perception and the warning strategy based on microscopic driving state.
    Zhao X; Li Q; Xie D; Bi J; Lu R; Li C
    Accid Anal Prev; 2018 Sep; 118():154-165. PubMed ID: 29496187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consumer perceptions of medication warnings about driving: a comparison of French and Australian labels.
    Smyth T; Sheehan M; Siskind V; Mercier-Guyon C; Mallaret M
    Traffic Inj Prev; 2013; 14(6):557-64. PubMed ID: 23859486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to multiple, prescribed medications in diabetic kidney disease: A qualitative study of consumers' and health professionals' perspectives.
    Williams AF; Manias E; Walker R
    Int J Nurs Stud; 2008 Dec; 45(12):1742-56. PubMed ID: 18701103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating three methods to encourage mentally competent older adults to assess their driving behavior.
    Uribe-Leitz T; Barmak LA; Park A; Howland J; Lee V; Lodato E; Driscoll C; Dechert T; Burke PA
    J Trauma Acute Care Surg; 2015 Jul; 79(1):125-31. PubMed ID: 26091325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Driving under the influence, public policy, and pharmacy practice.
    Sigona N; Williams KG
    J Pharm Pract; 2015 Feb; 28(1):119-23. PubMed ID: 25312259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.